Filed: 5/15/2026ACC: 0001615982-26-000011
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $2.68B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$2.68B
Total AUM (reported)
141.59M
Total Shares
Allocation by class
COM$2.16B80.8%
COM NEW$443.82M16.6%
CLASS A ORD SHS$38.29M1.4%
SPONSORED ADS$22.23M0.8%
COM SHS$11.24M0.4%
Portfolio Concentration
Top 3$1.18B44.2%
4–10$749.15M28.0%
11–25$643.44M24.0%
Rest$103.09M3.8%
Top 3 weight
44.2%
Top 10 weight
72.1%
Voting Authority Distribution
Total shares with voting rights: 141.59M
Sole
Full voting authority
141.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings33
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$714.88M
26.68%
Sole
8.49M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares16.38M
TypeSH
Market value$265.07M
9.89%
Sole
16.38M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares4.15M
TypeSH
Market value$203.48M
7.60%
Sole
4.15M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares3.69M
TypeSH
Market value$185.89M
6.94%
Sole
3.69M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.47M
TypeSH
Market value$130.33M
4.86%
Sole
6.47M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.18M
TypeSH
Market value$99.03M
3.70%
Sole
1.18M
Shared
0.00
None
0.00
DAMORA THERAPEUTICS INC
SOLEShares3.60M
TypeSH
Market value$93.33M
3.48%
Sole
3.60M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares10.35M
TypeSH
Market value$87.64M
3.27%
Sole
10.35M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares2M
TypeSH
Market value$76.98M
2.87%
Sole
2M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$75.95M
2.83%
Sole
3.88M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares13.74M
TypeSH
Market value$75.02M
2.80%
Sole
13.74M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares1.73M
TypeSH
Market value$67.67M
2.53%
Sole
1.73M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares4.32M
TypeSH
Market value$54.73M
2.04%
Sole
4.32M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares3.04M
TypeSH
Market value$54.26M
2.03%
Sole
3.04M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares1.60M
TypeSH
Market value$47.82M
1.78%
Sole
1.60M
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares9.98M
TypeSH
Market value$46.92M
1.75%
Sole
9.98M
Shared
0.00
None
0.00
JADE BIOSCIENCES INC
SOLEShares3.22M
TypeSH
Market value$45.25M
1.69%
Sole
3.22M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$39.41M
1.47%
Sole
2.17M
Shared
0.00
None
0.00
CRESCENT BIOPHARMA INC.
SOLEShares2.13M
TypeSH
Market value$39.19M
1.46%
Sole
2.13M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares6.43M
TypeSH
Market value$38.29M
1.43%
Sole
6.43M
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares4.84M
TypeSH
Market value$33.71M
1.26%
Sole
4.84M
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares4.77M
TypeSH
Market value$32.49M
1.21%
Sole
4.77M
Shared
0.00
None
0.00
TENAX THERAPEUTICS INC
SOLEShares1.68M
TypeSH
Market value$26.79M
1.00%
Sole
1.68M
Shared
0.00
None
0.00
ADLAI NORTYE LTD
SOLEShares3.21M
TypeSH
Market value$22.23M
0.83%
Sole
3.21M
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares8.70M
TypeSH
Market value$19.65M
0.73%
Sole
8.70M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $714.88M 26.68% | 8.49M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 16.38M | SH | $265.07M 9.89% | 16.38M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 4.15M | SH | $203.48M 7.60% | 4.15M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 3.69M | SH | $185.89M 6.94% | 3.69M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.47M | SH | $130.33M 4.86% | 6.47M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1.18M | SH | $99.03M 3.70% | 1.18M | 0.00 | 0.00 |
DAMORA THERAPEUTICS INCSOLE | COM NEW | 3.60M | SH | $93.33M 3.48% | 3.60M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 10.35M | SH | $87.64M 3.27% | 10.35M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 2M | SH | $76.98M 2.87% | 2M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $75.95M 2.83% | 3.88M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 13.74M | SH | $75.02M 2.80% | 13.74M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 1.73M | SH | $67.67M 2.53% | 1.73M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 4.32M | SH | $54.73M 2.04% | 4.32M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 3.04M | SH | $54.26M 2.03% | 3.04M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 1.60M | SH | $47.82M 1.78% | 1.60M | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 9.98M | SH | $46.92M 1.75% | 9.98M | 0.00 | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 3.22M | SH | $45.25M 1.69% | 3.22M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $39.41M 1.47% | 2.17M | 0.00 | 0.00 |
CRESCENT BIOPHARMA INC.SOLE | COM | 2.13M | SH | $39.19M 1.46% | 2.13M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 6.43M | SH | $38.29M 1.43% | 6.43M | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 4.84M | SH | $33.71M 1.26% | 4.84M | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 4.77M | SH | $32.49M 1.21% | 4.77M | 0.00 | 0.00 |
TENAX THERAPEUTICS INCSOLE | COM NEW | 1.68M | SH | $26.79M 1.00% | 1.68M | 0.00 | 0.00 |
ADLAI NORTYE LTDSOLE | SPONSORED ADS | 3.21M | SH | $22.23M 0.83% | 3.21M | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 8.70M | SH | $19.65M 0.73% | 8.70M | 0.00 | 0.00 |
Page 1 of 2